ArticleBMC gastroenterology2026
The predictive value of platelet-to-lymphocyte ratio and lymphocyte count in recurrent small intestinal hemorrhage: a retrospective cohort study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe recurrence of small intestinal hemorrhage (SIH) poses a significant clinical challenge owing to the absence of reliable and accessible predictive biomarkers. This study aimed to identify a crucial biomarker for predicting SIH recurrence and establish a benchmark to assist clinical decision-making.
methodsThe training cohort comprised 131 newly diagnosed SIH patients who underwent endoscopy at the First Affiliated Hospital of Nanchang University. An independent validation cohort included 96 patients from the Second Affiliated Hospital of Nanchang University. Major variables (MVs) were identified using Least Absolute Shrinkage and Selection Operator (LASSO) regression. A nomogram was developed by incorporating the coefficients of MVs from logistic regression, and its discrimination, calibration, and clinical utility were validated in both cohorts.
resultsDuring one year of follow-up, the bleeding recurrence rates were 41.22% in the training cohort and 30.21% in the validation cohort. Principal causes of bleeding included inflammatory bowel disease, vascular abnormalities, small intestinal diverticula, and small intestinal tumors, among others. The nomogram, based primarily on the Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte Count (LYM), achieved area under the curve (AUC) values of 0.923 and 0.784 in the training and validation cohorts, respectively. A nomogram score of 37.4 points was preliminarily identified as a potential threshold to distinguish the risk of bleeding recurrence within one year after endoscopic treatment in patients with small intestinal hemorrhage SIH.
conclusionThe nomogram developed in this study provides an effective tool for assessing the risk of recurrence after endoscopic treatment for small intestinal hemorrhage, demonstrating favorable predictive performance and offering a preliminary basis for clinical risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.